J&J CFO on acetaminophen: 'There's no basis to believe it's dangerous'

Joe Wolk, Johnson & Johnson CFO, joins Yahoo Finance's Adam Shapiro and Julie Hyman to discuss its fourth-quarter earnings report, talc baby powder, the current controversy around Acetaminophen and why the Johnson & Johnson board will not split its portfolio.

Advertisement